Search for: "Johnson and Johnson"
Results 7041 - 7060
of 32,220
Sorted by Relevance
|
Sort by Date
17 Oct 2024, 6:30 am
Johnson & Johnson (“Auris”) (Sept. 4, 2024) and SRS v. [read post]
29 Dec 2013, 6:19 am
DePuy Orthopaedics is the subsidiary of Johnson & Johnson. [read post]
24 Jun 2024, 1:01 pm
Johnson & Johnson subsidiary Janssen Products, LP, was found liable for the illegal off-label promotion and marketing of its HIV/AIDS-treatment drugs, Prezista and Intelence. [read post]
31 Mar 2011, 1:35 pm
Although Johnson & Johnson and DePuy Orthopaedics, Inc. have not recalled the DePuy Pinnacle Acetabular Cup System, the US Food and Drug Administration says that it has received reports indicating similar problems as those involving the DePuy ASR hip implants, which were recalled last year. [read post]
21 Nov 2008, 10:41 pm
After a 3 week trial, a Chicago jury found two Johnson & Johnson subsidiaries liable for the death of 38-year-old Janice DiCosolo, a mother of three.Duragesic is a patch containing a gel form of the opioid drug fentanyl, which is 100 times stronger than morphine. [read post]
12 Nov 2013, 2:37 pm
Johnson & Johnson is poised to pay over $4 billion to settle the their recalled hip implants. [read post]
29 Apr 2010, 2:06 am
., two subsidiaries of Johnson & Johnson, have agreed to pay $81 million to settle charges brought in two whistleblower suits that they violated the False Claims Act by promoting Topamax for off-label (unapproved) uses. [read post]
13 Jun 2011, 4:30 am
., a Johnson & Johnson subsidiary, under the state’s Unfair Trade Practices Act for deceptive marketing of its anti-psychotic drug, Risperdal. [read post]
21 Nov 2013, 11:32 am
Janssen, a Johnson & Johnson subsidiary, took a $4 million verdict in October. [read post]
26 May 2008, 12:20 pm
It’s an issue in drug cases, but it’s also now an issue in white collar case, as Kerri Kaley, a former Johnson & Johnson saleswoman, and her husband face charges of selling unwanted surgical supplies on the gray market. [read post]
7 Dec 2018, 7:39 am
A Johnson & Johnson pharmaceutical company, Actelion Pharmaceuticals US, Inc., settled with the US government for $360 million Thursday to resolve claims of illegally using a charity to receive kickbacks on Medicare patients. [read post]
4 Apr 2012, 9:42 am
Food and Drug Administration raised legitimate concerns over the defective product design more than a year before hip manufacturer Johnson & Johnson officially issued a recall. [read post]
9 Nov 2010, 4:30 am
A Louisiana jury in mid-October issued a $257.7 million verdict against Janssen Pharmaceutica, Inc. and its parent company, Johnson & Johnson, finding that the drugmaker misled Louisiana doctors about possible side effects of its antipsychotic drug Risperdal. [read post]
8 Dec 2010, 5:52 am
In August 2010, Depuy, a division of Johnson & Johnson, recalled hundreds of thousands of its ASR hip implant components from the American marketplace and began notifying physicians of the potential failure rates of these units. [read post]
20 Jul 2012, 11:52 am
Johnson & Johnson is the world’s largest consumer health company with perhaps the world’s largest public relations problem. [read post]
6 Oct 2010, 3:15 am
The Los Angeles Times reports, “The head of pharmaceuticals giant Johnson & Johnson, testifying on the massive recall of its widely used children’s pain relievers, admitted Thursday that ‘we did not maintain our high quality standards,’” and consequently, “children do not have access to our important medicines,” Chief Executive William C. [read post]
26 Oct 2010, 7:09 am
DePuy Orthopedics, a division of Johnson & Johnson, has recalled the ASR XL Acetabular System, a prosthesis used in total hip replacements. [read post]
15 Jul 2012, 7:00 pm
Johnson & Johnson revealed last week that it intends on providing more corporate oversight of its drug manufacturing and marketing practices. [read post]
18 Nov 2010, 12:59 pm
Johnson & Johnson, No. 35500, slip op. [read post]
15 Jul 2012, 7:00 pm
Johnson & Johnson revealed last week that it intends on providing more corporate oversight of its drug manufacturing and marketing practices. [read post]
